A strategy, a plan, but above all, action!

The Flemingsberg Science Foundation board approved its business plan for 2022 in January. This essentially paves the way for an increase in the pace of business set-ups and opportunities to innovate in Flemingsberg. Almost six months on, what have we achieved?

In May, we unveiled the new campusflemingsberg.se website, which provides details of courses, businesses, services, environments, core facilities, collaborations and innovations. Building awareness and facilitating networking are key steps to enable more businesses to establish themselves and give existing actors new opportunities to find each other and to make contact with one another.

We also launched the Flemingsberg Business Community in May to create a meeting place for campus businesses to discuss key issues in the development of the business environment in Flemingsberg.

The period has also seen Pernilla and I move into new premises. We are now based in A Working Lab’s premises on Alfred Nobels Allé 10.

The first six months of the year also included a large number of meetings with businesses, property owners, municipalities and representatives from Region Stockholm. Everyone we meet expresses a strong desire to contribute to our work on business start-ups and to strengthen site marketing of Flemingsberg. This involves tackling details as well as having the capacity to take on the big issues, those that take a little longer to address.

Spring was quite intense but above all, it was very stimulating. The Foundation would like to wish everyone a wonderful summer! I hope and believe that autumn will be successful.

Building a heart: Realheart aims to create new opportunities for patients with heart failure

A mechanical heart, as close to a human heart as it gets. Realheart is the company developing a total artificial heart for patients with advanced heart failure, a condition where treatment options are often limited. When we sit down with CEO Ina Laura Perkins, she tells the story of an innovation that has taken its time, about the strong drive to reach all the way to patients, and about steps that are bringing the company closer to clinical reality.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2022-06-23T09:07:09+02:00
Go to Top